Are any oral iron formulations better tolerated than ferrous sulfate?

Journal of Family Practice

Volumn 51, Issue 6, 2002, Pages 576-

  McDiarmid, Todd ^a   Johnson, E Diane ^a  

^a Moses Cone Family Medicine Residency Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRO GRAD 500; FERROUS SULFATE; IRON SACCHARATE;

ADULT; AGED; DRUG EFFECT; DRUG FORMULATION; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; SHORT SURVEY;

ANEMIA, IRON-DEFICIENCY; EVIDENCE-BASED MEDICINE; FERROUS COMPOUNDS; HUMANS; IRON, DIETARY; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0036270298     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form
2. Side-effect studies on a new sustained release iron preparation
3. Adverse effects of iron supplementation: A comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets
4. A comparative trial of slow-release and conventional iron preparations
5. Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors
6. On the therapeutic effects of trivalent and divalent iron in iron deficiency anaemia
7. High-dose carbonyl iron for iron deficiency anemia: A randomized double-blind trial
8. Bioavailability of carbonyl iron: A randomized, double-blind study